Lung cancer health disparities
BM Ryan - Carcinogenesis, 2018 - academic.oup.com
Compared with all other racial and ethnic groups in the United States, African Americans are
disproportionally affected by lung cancer, both in terms of incidence and survival. It is likely …
disproportionally affected by lung cancer, both in terms of incidence and survival. It is likely …
Chemical Biology of Double Helical and Non-Double Helical Nucleic Acids: “To B or Not To B, That Is the Question”
N Sugimoto, T Endoh, S Takahashi… - Bulletin of the …, 2021 - academic.oup.com
Nucleic acids form not only the canonical double helix (duplex) but also the non-canonical
(non-double helix) structures such as triplexes, G-quadruplexes, and i-motifs. The formation …
(non-double helix) structures such as triplexes, G-quadruplexes, and i-motifs. The formation …
Methods for using race and ethnicity in prediction models for lung cancer screening eligibility
Importance Using race and ethnicity in clinical prediction models can reduce or inadvertently
increase racial and ethnic disparities in medical decisions. Objective To compare eligibility …
increase racial and ethnic disparities in medical decisions. Objective To compare eligibility …
Immune-based cancer treatment: addressing disparities in access and outcomes
RU Osarogiagbon, HM Sineshaw, JM Unger… - American Society of …, 2021 - ascopubs.org
Avoidable differences in the care and outcomes of patients with cancer (ie, cancer care
disparities) emerge or worsen with discoveries of new, more effective approaches to cancer …
disparities) emerge or worsen with discoveries of new, more effective approaches to cancer …
[HTML][HTML] ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer
with an abysmal prognosis rate over the last few decades. Early diagnosis and prevention …
with an abysmal prognosis rate over the last few decades. Early diagnosis and prevention …
[HTML][HTML] Cardiotoxicity risk factors with immune checkpoint inhibitors
ZL Brumberger, ME Branch, MW Klein, A Seals… - Cardio-Oncology, 2022 - Springer
Background Checkpoint-inhibitor immunotherapies have had a profound effect in the
treatment of cancer by inhibiting down-regulation of T-cell response to malignancy. The …
treatment of cancer by inhibiting down-regulation of T-cell response to malignancy. The …
Identification and validation of key genes associated with non‐small‐cell lung cancer
Q Ma, Y Xu, H Liao, Y Cai, L Xu, D Xiao… - Journal of cellular …, 2019 - Wiley Online Library
Non‐small‐cell lung cancer (NSCLC) is one of the main causes of death induced by cancer
globally. However, the molecular aberrations in NSCLC patients remain unclearly. In the …
globally. However, the molecular aberrations in NSCLC patients remain unclearly. In the …
MicroRNA expression patterns in oral squamous cell carcinoma: hsa‐mir‐99b‐3p and hsa‐mir‐100‐5p as novel prognostic markers for oral cancer
Background MicroRNAs (miRNA) recently evolved as potential cancer biomarkers.
Therefore, the aim of the present study was to evaluate the prognostic impact of eight …
Therefore, the aim of the present study was to evaluate the prognostic impact of eight …
[HTML][HTML] Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS‑mutated lung cancer cells
M Wang, X Chen, G Fu, M Ge - Oncology Reports, 2022 - spandidos-publications.com
Kirsten rat sarcoma viral oncogene homolog (KRAS) aberrations frequently occur in patients
with lung cancer. Oncogenic KRAS is characterized by excessive reactive oxygen species …
with lung cancer. Oncogenic KRAS is characterized by excessive reactive oxygen species …
[HTML][HTML] Prognostic significance of TOP2A in non-small cell lung cancer revealed by bioinformatic analysis
W Ma, B Wang, Y Zhang, Z Wang, D Niu, S Chen… - Cancer cell …, 2019 - Springer
Background Lung cancer has been a common malignant tumor with a leading cause of
morbidity and mortality, current molecular targets are woefully lacking comparing to the …
morbidity and mortality, current molecular targets are woefully lacking comparing to the …